Abstract
Abstract Complex etiologic heterogeneity among non-Hodgkin's lymphoma (NHL) subtypes has made it difficult to identify risk factors for this disease. However, recent genetic association analyses, including two genome-wide association studies, suggest that genetic susceptibility to NHL may be strongest for the follicular lymphoma subtype. As recent studies have demonstrated that microRNAs (miRNAs) may be important in the etiology of many cancer types, including NHL, we performed a population-based genetic association study which identified a polymorphism in the precursor of miR-202 that is strongly associated with follicular lymphoma risk (rs12355840 in miR-202: PTREND = 0.006). An in vitro functional genetics assay demonstrated that the polymorphism is biologically active, and operates by altering the processing efficiency of the miR-202 precursor to the mature effector miRNA species. A ribonucleoprotein immunoprecipitation-microarray (RIP-Chip) assay, performed with an anti-AGO2 antibody followed by a whole-genome array, was used to characterize the miR-202 targetome, and selected targets were confirmed using a 3′UTR luciferase assay. Among the identified targets were several transcripts with relevance for tumorigenesis, including the miRNA biogenesis gene DICER1 and the lymphoma-associated cell cycle regulator and proto-oncogene SKP2. Both of these genes have been shown to be upregulated in lymphomas, which is consistent with our data, which show that the miR-202 risk allele is associated with diminished mature miR-202 levels in vitro. Taken together, these findings suggest that rs12355840 may represent a novel risk biomarker for follicular lymphoma, and implicate miR-202 in follicular lymphomagenesis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1652. doi:1538-7445.AM2012-1652
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
